Curanex Pharmaceuticals (NASDAQ:CURX) Share Price Breaks Below 50-Day Moving Average – Time to Sell?

Curanex Pharmaceuticals Inc (NASDAQ:CURX)’s stock price passed below its 50-day moving average during trading on Friday. The stock has a 50-day moving average of $4.94 and traded as low as $4.59. Curanex Pharmaceuticals shares last traded at $4.8340, with a volume of 6,252 shares trading hands.

Analyst Ratings Changes

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of Curanex Pharmaceuticals in a research note on Tuesday, October 27th. One analyst has rated the stock with a Sell rating. Based on data from MarketBeat, Curanex Pharmaceuticals presently has a consensus rating of “Sell”.

Curanex Pharmaceuticals Stock Down 14.7%

The business has a fifty day moving average of $4.94 and a 200 day moving average of $6.09. The company has a market cap of $7.59 million, a P/E ratio of -0.62 and a beta of -2.99.

Curanex Pharmaceuticals (NASDAQ:CURX) last released its quarterly earnings results on Friday, November 13th. The company reported ($1.86) earnings per share for the quarter.

Curanex Pharmaceuticals Company Profile

Curanex is a developmental stage pharmaceutical company dedicated to discovering, developing and commercializing innovative botanical drugs to treat patients suffering from inflammatory diseases. Our mission is to address significant unmet medical needs and improve patients’ lives by harnessing the power of natural substances. We are dedicated to discovering, developing and commercializing botanical medicines for treating patients with immune and inflammatory diseases and to develop therapies that may offer potential benefits to patients with unmet clinical needs in various fields, such as autoimmune diseases, metabolic diseases and viral infections.